- Email: [email protected]
APhA 1992 Annual Meeting Podium Sessions and Posters of Contributed Papers
APhA 1992 Annual Meeting Podium Sessions and Posters of Contributed Papers American Pharmaceutical Association (APhA) annual meetings provide pharmacists with an unparalleled opportunity to keep up-to-date on the latest information in health care delivery) legal aspects of pharmacy) clinical advancements) practice innovations) new ideas in nuclear pharmacy) and the latest in scientific breakthroughs. Published abstracts of the papers listed here will be available in the Annual Meeting Final Program to be distributed at the 139th Annual Meeting and Exposition in San Diego) California) March 14-18) 1992.
11:15 Pharmacist Intervention in Smoking Cessation: A Review of the Literature. Kent H. Summers, University of Mississippi, University. (abstract #69) 11:40 Recruitment of State Pharmacy Association Members by Pharmacy Students. Robert P. Marshall, California Pharmacists Association, Los Angeles, and Julie Tennenhouse, Student Membership Recruiter, University of California , San Francisco . (abstract #72)
110 American Society for Pharmacy Law Contributed Papers I Saturday) March 14) 10:00 am-1:00pm 0.30 CEU
Podium Sessions The podium sessions are listed here, including the session number, category, day, date, paper titles, and times. Contributed paper podium sessions are 20- to 30-minute discussions, including a 5-minute question and answer period. Boldface indicates the principal author. Don't miss this "user friendly" way to participate in a valuable continuing education activity. Continuing education credit is offered for participation in podium sessions.
108 APhA/Academy of Pharmacy Practice and Management Contributed Papers Podium Session I Saturday) March 14) 10:00am-noon 0.20 CEU 10:00 Risk Perceptions of Self-Medication Practices. Yomma Tezino, Nawarut Charupatanapong, and Mary-Ann Galley, Texas Southern University, Houston. (abstract #63) 10:25 An Evaluation of Ni~e Risk Reduction Strategies for SelfTreatment. Nawarut Charupatanapong, Rashmi Gupta, and Mary Thompson, Texas Southern University, Houston. (abstract #64)
10:00 Drug Use Review in the Context of Recent Federal Legislation. Francis B. Palumbo, University of Maryland, Baltimore. (abstract #108) 10:20 Food and Drug Administration Approved Drugs for Unapproved Uses. Constant G. Marquer , Jr., and Brenda Thomas, Xavier University, New Orleans, La. (abstract #100) 10:40 Prozac: Side-Effects Causing a Nationwide Depression. J o se p h william Moch, Grand Rapids, Mich. (abstract #104) 11:00 Evaluating the Professional Competence of Pharmacists. Richard R. Abood, University of the Pacific, Stockton, Calif. (abstract #106) 11:20 The Pharmacist's Role in the Provision of Risk Management and Risk Assessment Information for Prescription Drugs: Preliminary Findings. Joseph B. Wie d erholt and Jon C. Schommer, University of Wisconsin-Madison, and David B. Brushwood, University of Florida, Gainesville. (abstract #102) 11:40 Interference with the Physician-Patient Relationship: A Potential New Avenue of Liability for the Pharmacist. Christopher P. Orlando, St. Clare's Hospital and Health Center, New York, N.Y. (abstract #99) 12:00 The Legal Ramifications of Special Dispensing Situation. Frederick H. Fern, Lester Schwab Katz & Dwyer, New York, N.Y. (abstract #96) 12:20 Pharmacist, Abortion, and Conscience. David B. Brushw ood, University of Florida, Gainesville. (abstract #97)
10:50 OTC Medication Recommendation by Retail Pharmacy Support Personnel: Prevalence and Governance by Store Policy. David J. McCaffrey ill, Benjamin F. Banahan III, and Mickey C. Smith, University of Mississippi, University. (abstract #67)
AMERICAN PHARMACY
February 1992/158 Vol. NS32, No.2
119 APhA/Academy of Pharmacy Practice and Management Contributed Papers Podium Session II
2:20 Physician Response to a Medicaid DUR Program. Earlene E. Lipowski, University of Florida , Gainesville, and Marion Becker, University of Wisconsin-Madison. (abstract #14)
Saturday, March 14, 2:00 pm-4:oo pm 0.20 CEU
2:40 Pharmacists' Reactions to a Medicaid DUR Program. Carolyn M. Brown and Earlene E. Lipowski, University of Florida, Gainesville. (abstract #15)
2:00 The Hispanic Patient: Challenges and Opportunities for Pharmacists. H.A. Monsanto, M. Rodriguez de Bittner, University of Maryland, Baltimore. (abstract #81) 2:25 Appropriateness of H2-Receptor Antagonist Prescribing for the Ambulatory Elderly. D.L. McNally, S.M. Speedie, and S.] . Skarupa, University of Maryland, Baltimore. (abstract #76) 2:50 Needs Assessment for a Third Class of Drugs: Results in Selected Consumer Samples. Marion K. Slack and Nancy A. Alvarez, University of Arizona, Tucson. (abstract #75) 3:15 The Role of Pharmacists in OTC Drug Product Selection Decisions: Review of the Literature. Kent H. Sununers and Foo Nin Ho, University of MissisSippi, University. (abstract #73)
3:40 Hepatitis B Immunization Program for Pharmacy Students. Hanaa Salm, Patrick Catania, Arthur Harralson, and Donald Sorby. University of the Pacific, Stockton, Calif. (abstract #82)
120 Economic, Social and Administrative Sciences Contributed Papers Podium Session I
3:00 Effect of Health Education on Health Service Utilization Among Hypertensive Patients Enrolled in Health Maintenance Organizations. D.A. ScIar and T.L. Skaer, Washington State UniverSity, Pullman; and A. Chin, M.P. Okamoto, R.K. Nakahiro, and M.A. Gill, University of Southern California, Los Angeles. (abstract #16) 3:20 Examination of Days Supply in Computerized Prescription Claims. Karen B. Farris, Barbara Kaplan, and Duane M. Kirking, University of Michigan, Ann Arbor. (abstract #17) 3:40 AsseSSing Compliance to Antihypertensive Medications Using Computer-Based Pharmacy Records. Dale B. Christensen, B. Williams, H. Goldberg, R. Engelberg, D. Martin, and ]. LoGerfo, University of Washington, Seattle. (abstract #18)
309 Nuclear Pharmacy Contributed Papers/Update Monday, March 16, 1:00-5:00 pm 0.40 CEU
Saturday, March 14, 2:00 pm-4:oo pm 0.20 CEU
Effectance vs. Effective Dose EqUivalent for Estimating Radiation Risk from Radiopharmaceuticals. James A. Ponto, University of Iowa, Iowa City. (abstract #88)
2:00 Pharmacist Self Concept, Predisposition to Communicate, Desire to Counsel, and Job Satisfaction. H.M. AndersonHarper, B.A. Berger, and O.R. Noel, Auburn University, Ala. (abstract #7)
Magnetic Resonance Spectroscopy and Nuclear Medicine. Kenneth T. Cheng, Timothy Nagel, and Kenneth M. Spicer, Medical University of South Carolina, Charleston. (abstract #90)
2:20 Relationships Between Patient Counseling Events, Prescription Payment Methods, and Practice Settings in Community Pharmacy. Dennis W. Raisch, University of New Mexico, Albuquerque. (abstract #8)
Preparation, Quality Control, and Clinical Investigation Using [llllIn-Labeled 1A3, A Monoclonal Anticolorectal Carcinoma Antibody for Patients. S.W. Schwarz, P.A. Rocque, c.]. Anderson, M.). Welch, ].M. Connett, and G.W. Philpott, Washington University Medical School, St. Louis, Mo. (abstract #93)
2:40 Pharmacists' Views of Patient Counseling: Preliminary Findings from a Statewide Study. Jon c. Schommer and Joseph B. Wiederholt; Sonderegger Research Center, University of Wisconsin-Madison. (abstract #9) 3:00 Determinant Attributes and Market Segments for Multiple Source Pharmaceuticals. Ebere F. Igboko and Joseph Thomas III, Purdue University, West Lafayette, Ind. (abstract #10) 3:20 An Investigation of the Importance of Certain Factors for HMO Drug Formulary Selection Decisions. Elizabeth C. Hanson, University of North Carolina, Chapel Hill; Marvin D. Shepherd , University of Texas , Austin ; and Andreas M. Pleil , Pharmaco. (abstract #11) 3:40 Relationship Between the Number of Firms and Generic Price Competition. ThanigaveIan Jambulingam and David H. Kreling, University of Wisconsin-Madison: (abstract #12)
201 Economic, Social and Administrative Sciences Contributed Papers Podium Session II Sunday, March 15, 2:00 pm-4:oo pm 0.20 CEU 2:00 Effect of Medication Utilization Review on Medicaid Health Care Expenditures: Four-Year Experience Among Patients with Non-Insulin-Dependent Diabetes Mellitus. D.A. ScIar and T.L. Skaer, Washington State University, Pullman. (abstract #13) Vol. NS32, No.2 February 19921159
Use of Bar Coding in the Nuclear Pharmacy. Robert F. Gutkowski, William C. Porter, and Jack c. Hill, William Beaumont Hospital, Royal Oak, Mich. (abstract #94) Source, Magnitude and Possible Solutions to Potential Radioactive Releases During Production of [18F1Fluorodeoxyglucose (FDG). G. Leonard Watkins, Richard D. Hichwa, John C. Richmond, and Laura L Boles Ponto, University of Iowa, Iowa City. (abstract #95)
400 Economic, Social and Administrative Sciences Contributed Papers Podium Session III Tuesday, March 17, 8:00am-10:ooam 0.20 CEU 8:00 Drug Use Behavior Beyond the Medicaid Prescription Cap. Richard M. Schulz, Sandy Chubon, Marcy Coster-Schulz, and Earle W. Lingle, University of South Carolina, Columbia. (abstract #19) 8:20 Use of Home Remedies and OTC Products Among Rural Residents at High Risk for Development of Coronary Heart Disease. Benjantin F. Banahan m and Dennis A. Frate, University of MissiSSippi, University. (abstract #20) 8:40 Clients' Experience of Side Effects and Discontinuation of Oral Contraceptives. Betty Chewning and Dale Wilson, Son-
AMERICAN PHARMACY
deregger Research Center, University of Wisconsin-Madison. (abstract #21) The Effect of Patient's Age and Payment Method on Satisfaction w ith Pharmacy Services. Lon N. Larson, Drake University, Des Moines, Iowa, and Linda D . MacKeigan, Ohio State University, Columbus. (abstract #22)
Medical Utilization of Elderly Hypertensives. L. Douglas Ried, University of Florida, and Richard E. Johnson, Center for Health Research, Gainesville, Fla. (abstract #26)
3:20
9:00
Quality of Life for Parents of Children with Asthma . Joseph T. Dye, Richard M. Schulz, Lynn M. Jolicoeur, and Thomas P. Cafferty, University of South Carolina, Columbia. (abstract #23)
9:20
Estimating Sample Sizes from an Elderly Population. Chris M. Kozma, Earle W. Lingle, and ].S. Roberts, University of South Carolina, Columbia. (abstract #24)
The Use of Antibiotics in Saskatchewan. Jeffrey S. McCombs and Michael B. Nichol, University of Southern California , Los Angeles. (abstract #27)
3:40
Zidovudine Use Among Symptomatic HIV Cases in the New York State Medicaid Program, 1987-1989. Leon E. CosIer, Lynne Oetjen-Gerdes, and Thomas R Fanning, New York State Dept. of Social Services, New York; Leona E. Markson and Barbara ]. Turner, Jefferson Medical College, New York. (abstract #28)
4:00
9:40
409 American Society for Pharmacy Lavv Contributed Papers II
Differences in Prescribing Rates Among Rural and Urban Physicians: An Analysis of the National Ambulatory Medical Care Survey. David W. Miller and Stuart M. Speedie, University of Maryland, Baltimore. (abstract #29)
4:20
Physicians' Product Class Choice in Treating Mild Hypertension: A National Survey of a Sample of Physicians. J. Martin Jernigan, Mickey C. Smith, Benjamin F. Banahan III, John P. Juergens, and Thomas R Sharpe, University of Mississippi, University. (abstract #30)
4:40
Tuesday, March 17, 8:30 am-ll:30 am 0.30 CEU Legal Status of the Pharmacist as an Employee. Robert A. Hollenbeck, Hospital of St. Raphael, New Haven, CT. (abstract #109)
8:30
The Wisconsin Pharmacy Self-Inspection Project: An Application of the Theory of Continuous Improvement. Jon C. Schommer, Joseph B. Wiederholt, and T.D. McGregor, University of Wisconsin-Madison. (abstract #101)
8:50
Regulation of Pharmacist Time and Workplace Conditions-Necessary or Overly Burdensome? Michelle Dains, Texas State Board of Pharmacy, Austin. (abstract #103)
9:10
Adapting the Public Utility Model to Health Care Systems: Focus-Pharmaceutical Care. Richard A. Angorn and Maria A. Miralles, University of Florida, Gainesville. (abstract #98)
9:30
A Survey of Pharmacist Patient Counseling Laws by State and Their Impact on Pharmacy Practice. Deborah A. Carlino and Norman A. Campbell, University of Rhode Island, Kingston. (abstract #111)
9:50
10:10 The Public Policy and Economic Implications of DUR for Pharmacy. Jennifer L. Tebbe and F. Randy Vogenberg, Mas-
sachusetts College of Pharmacy and Allied Health Sciences, Boston. (abstract #107)
Poster Sessions Sunday, March 15, 11:00 am-3:00pm Monday, March 16, 11:00 am-3:00 pm Tuesday, March 17, 11:00 am-3:00 pm
This year there will be four poster sessions. The APhA Contributed Papers Poster Sessions will be held on Sunday, Monday, and Tuesday. Authors will be present on Sunday only. The Economic, Social and Administrative Sciences (ESAS) Contributed Papers Poster Session will be held only on Sunday with authors present. (No CE credit is offered.)
Academy of Pharmaceutical Research & ScienceIBasic Sciences Contributed Papers Poster Session 1.
Effect of pH on the Dissolution of Commercially Available Procainamide Controlled-Release Products. Ashesh]. Gandhi and J. Grady Strom, Jr., Mercer University, Atlanta, Ga . (abstract #1)
2.
Radiopharmaceutical Metabolism by Cultured Hepatocytes: Validation of Methodology Using [1-123Hofetamine. S.M. MoerIein, RA. Weisman, D. Beck, A.P . Li, and M.J. Welch, Washington University School of Medicine and Monsanto Corporation, St. Louis, Mo. (abstract #2)
3.
Preparation of Gallium-68 Labeled Human Lipoproteins for PET Assay of Tissue LDL Receptor Activity. S.M. Moerlein, C. Yahng, and MJ. Welch, Mallinckrodt Institute of Radiology, Washington University, St. Louis, Mo. (abstract #3)
412 Economic, Social and Administrative Sciences Contributed Papers Podium Session IV
4.
Encapsulation of High Molecular Weight DNA and Release from Calcium Alginate Hydrogels. Timothy J. Smith, Indiana University, Terre Haute. (abstract #4)
Tuesday, March 17, 3:00pm-5:00 pm 0.20 CEU
5.
Evaluation of Maltodextrins as Tablet Excipients: I Micromeritic and Compressional Characterization. Shelli Nath and Yashwant V. Pathak, South Dakota State University, Brookings. (abstract #5)
10:30 Consumer Protection Issues Surrounding the Mail Order Prescription Controversy. Norman A. Campbell, University of
Rhode Island, Kingston. (abstract #110) 10:50 A Call for the Use of Conflict of Laws Doctrine to Enforce
State Board Regulation of Mail-Order Pharmacy. Gregory J. Wood, Canton, Ohio. (abstract #112) 11:10 Litigation Between Pharmaceutical Manufacturers: 1980--Present. Martha M. Rwnore, Alan Pescheria, and Steven S. Strauss, Arnold & Marie Schwartz College of Pharmacy, New
York, N.Y. (abstract #105)
Health Care Costs and Antihypertensive Drug Therapy. J.S. McCombs, D.A. Sclar, M.B. Nichol, and C.M. Newman, University of Southern California, Los Angeles. (abstract #25)
3:00
AMERICAN PHARMACY
February 1992/160 Vol. NS32, No.2
6.
In Vitro Adsorption and Desorption Studies of Sulindac with Antacids . Fotios M. Plakogiannis, Tahmina Z. Mannan , Theodore Jochsberger, and Almas Babar, Long Island University, Brooklyn, N.Y. (abstract #6)
Academy of Pharmacy Practice and Management Contributed Papers Poster Session National Hospice Pharmacy Survey. Stephen G. Arter, Parkview Memorial Hospital, Fort Wayne, Ind., and Joni 1. Berry, Hospice of Wake County, Raleigh, N.C. (abstract #62)
7.
8.
Using the Delphi Technique to Determine Guidelines for Developing a Community Pharmacy Clinical Clerkship Model. J.H. McDermott, S.M. Caiola , and K.F. Kuhn, University of North Carolina, Chapel Hill. (abstract #65)
9.
Development of an Industrial Pharmacy Career Curriculum Option. Z. Tom Grapes and Richard A. Jackson, Mercer University, Atlanta, Ga. (abstract #66)
10. Development of an In-House Clinical Skills Development Program. Andrew J. Donnelly, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Ill. (abstract #68) 11. Streamlining an OB Anesthesia Work Area Through Stock Revision and Policy and Procedure Enhancement. Julie A. Golembiewski, University of Illinois Hospital, Chicago. (abstract #70)
12. Creation of the California Pharmacy Council. Robert P. Marshall, California Pharmacisl~ Association, Los Angeles, and Teresa A. Miller, California Society of Hospital Pharmacists. (abstract #71) 13. Job and Career Satisfaction: Rural versus Urban Pharmacists. Marion K. Slack and Michelle Kikuchi, University of Arizona, Tucson. (abstract #74)
Academy of Students of Pharmacy Contributed Papers Poster Session 22. Student Awareness of and Extent of Participation in State Pharmaceutical Association Activities. H.A. Monsanto and S.l. Lugo, University of Maryland, Baltimore; E. Vega, 1. IgleSias, and F. Morales, University of Puerto Rico, San Juan. (abstract #113)
Nuclear Pharmacy Contributed Papers Poster Session 23. Establishment and Economic Feasibility of Nuclear Pharmacy Services in a Rural Community Setting. David 1. Laven, Veterans Affairs Medical Center, Bay Pines, Fla., and Timothy M. Quinton, Radiopharmacy, Inc., Evansville, Ind. (abstract #89) 24. An Innovative Nuclear Pharmacy Service: A Comprehensive Management Plan for Clinical Investigations. K.T. Chen, B.M. Brown, M.S. Sheppard, and D.]. Haymond, Medical University of South Carolina, Charleston. (abstract #91) 25. A Study to Investigate Preparation Parameters of TC-99M Teboroxime . B.M. Brown, K.T. Cheng, M.S. Sheppard, and D.] . Haymond, Medical University of South Carolina, Charleston. (abstract #92)
APhA Merck Student Pharmacy Project Grants 26. Geriatric Patient Drug Education Program. The APhA-ASP Chapter at Purdue University, West Lafayette, Ind. (abstract #114)
14. Evaluation of Unclaimed Prescriptions in an Ambulatory Care Pharmacy. Marilyn H. Kirking and Duane M. Kirking, University of Michigan, Ann Arbor. (abstract #77)
27. The Impact of Pharmacy Education to High School Students on the Prevention of Acquired Immunodeficiency Syndrome (AIDS). The APhA-ASP Chapter at Rutgers University, Piscataway, N.]. (abstract #115)
15. An Analysis of the Financial Impact of Third Party Programs on Community Pharmacy. Cheryl Huey, Richard A. Jackson, and Margaret A. Piril, Mercer University, Atlanta, Ga. (abstract #78)
28. The Use of Poison Control Stickers to Prevent the High Incidence of Poison Related Injuries and Deaths. The APhA-ASP Chapter at the University of the Pacific, Stockton, Calif. (abstract #116)
16. Medication Management and Compliance in Assisted Living Facilities (ALF). L Maine, N. Barfield, M. Feemster, and B. Murray, Samford University, Birmingham, Ala. (abstract #79)
29. Establishment of a Pharmacy Student Council on Substance Abuse Education. The APhA-ASP Chapter at the University of Utah, Salt Lake City. (abstract #117)
17. Misconceptions and Use of Vitamin/Mineral Supplements in the Low Income Elderly. Mary Thompson, Nawarut Charupatanapong, and Mary-Ann Galley, Texas Southern University, Houston. (abstract #80)
30. "Ask Your Pharmacist" Informational Radio Announcements. The APhA-ASP Chapter at the University of Oklahoma, Oklahoma City. (abstract #118)
18. A Comparison of On-Line Prospective DUR in a Medicaid Versus a Non-Medicaid Population. Pat Mundy, Pharmacist Consultant for The Computer Company of Virginia, Glen Allen. (abstract #83) 19. Educating the Patient's Families on Their Level. Judy Ann Knapp and Victoria Hyde, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. (abstract #84) 20. Pharmacoeconomic Impact of GERD-A Feasibility Study in a Community Pharmacy. LJ. Kirchdoerfer, Glaxo Inc., Research Triangle Park, N.C. , and R.]. Osterhaus and M.C. Osterhaus, Osterhaus Pharmacy, Inc. , Maquoketa, Iowa. (abstract #85) 21. The FDA Drug Quality Reporting System and Drug Shortage Program. Anita M. Dopkosky and George R. Bolger, FDA, Rockville, Md. (abstract #120)
Vol. NS32, No.2 February 1992/161
31. EmbraCing me Future: Coping with the Stresses of a Changing Profession. A MultidiSCiplinary Conference. The APhA-ASP Chapter at Drake University, Des Moines, Iowa. (abstract #119)
Economic, Social, and Administrative Sciences Contributed Papers Poster Session 32. The Impact of the Rhode Island Duplicate Prescription Law on Prescribing Practices for Schedule II Drugs-Part 1. Self-Stated Effect of the Law on Drug Regimen Decision-Making Process. Bridgit A. Anness, Cynthia]. Willey, Albert H. Taubman, Norman A. Campbell, and Charles Hacadorian, University of Rhode Island, Kingston. (abstract #31)
AMERICAN PHARMACY
33. The Impact of the Rhode Island Duplicate Prescription Law on Prescribing Practices for Schedule II Drugs---Part II. Self-Stated Effect of the Law on Therapeutic Preference to Choose an Alternative Drug to a Clearly Indicated Schedule II Drug. Bridgit A. Anness, Cynthia J. Willey, Albert H. Taubman, Norman A. Campbell, and Charles Hachadorian, University of Rhode Island, Kingston. (abstract #32)
48. Prescription Payer Mix Analysis of a Nationwide Secondary Database. Paul G. Rosowski and David H. Kreling, University of Wisconsin-Madison. (abstract #47)
34. Do Mandatory Consultation and Patient Profile Laws Represent New Professional Standards or Simply Wishful Thinking? Lucy Michael and Michael B. Nichol, University of Southern California, Los Angeles. (abstract #33)
50. Pharmacists' Expectations vs. Satisfactions with Brand Name Manufacturers. Puneet Mahajan, Harvey Rappaport, Kai Wong, and Priti Jhingran, Northeast Louisiana University, Monroe. (abstract #49)
35. Needs Assessment for a Third Class of Drugs: Results in Selected Consumer Samples. Marion K. Slack and Nancy A. Alvarez, University of Arizona, Tucson. (abstract #34)
51. Product Attributes Considered in the Selection of an Rx-toOTC Switch Candidate: The Opinion of the Pharmaceutical Marketing Executives. Priti Jhingran, Harvey Rappaport, Joseph Feldhaus, Aubrey Magoun, and William Weirick, Northeast Louisiana University, Monroe. (abstract #50)
36. Impact of a Discounted AWP on Drug Product Selection for Medicaid Prescriptions. Dean Arneson, Ferris State UniverSity, Big Rapids, Mich.; Elgene Jacobs, University of Oklahoma, Oklahoma City; and James R. Schmidt, University of Nebraska , Omaha. (abstract #35)
37. Physician Prescribing Decisions: The Effects of Situational Involvement and Task Complexity on Information Acquisition and Decision Making. Vigit Chinburapa, West Virginia University, Morgantown; Lon N. Larson, Drake UniverSity, Des Moines; J. Lyle Bootman, JoLaine Draugalis, Merrie Brucks, and Christopher P. Puto, University of Arizona , Tucson. (abstract #36) 38. The Importance of Side Effects in Differentiating Prescription Drug Products. Vigit Chinburapa, West Virginia University, Morgantown, and Lon N. Larson, Drake UniverSity, Des Moines, Iowa. (abstract #37) 39. Practical Evaluation of the Psychometric Properties of a Disease Specific Quality of Life Instrument in Clinical Practice. J.T. Lee and J.D. Hirsch, Glaxo Inc. Research Institute, Research Triangle Park, N.C. (abstract #38) 40. An AnalysiS of the Cost of Dispensing Third Party and Private Pay Prescriptions in Rhode Island. Kenneth W. Schafenneyer and Renato Cataldo, Jr., St. Louis College of Pharmacy, St. Louis, Mo. (abstract #39) 41. Disease and Therapy Characteristics of Home Infusion Therapy Patients. Chris M. Kozma, Bryan J. Lawrence, and C. Eugene Reeder, University of South Carolina, Columbia. (abstract #40)
42. Characterization of the Home Infusion Market in North Carolina and Florida. Terri Young, Chris M. Kozma, C. Eugene Reeder, and Earle W. Lingle, University of South Carolina, Columbia. (abstract #41) 43. Adequacy of the FDA's Prescription to Over-the-Counter Switch Evaluation Criteria: An Empirical Investigation. Suresh Madhavan, West Virginia University, Morgantown. (abstract #42)
49. Consumer Selection of Generic and Brand Name Prescription Medications After a Brand Name Petition Process. K.c. Fanner, E.W. Jacobs, and c.R. Phillips, University of Oklahoma, Oklahoma City. (abstract #48)
52. Product Attribute Importance in Evaluating a New Antihypertensive Product Among a Sample of Physicians. J. Martin Jernigan, Mickey C. Smith, Benjamin F. Banahan III , John P. Juergens, and Thomas R. Sharpe, University of Mississippi, UniverSity. (abstract #51)
53. Rural High School Students' Attitudes Toward and Use of OTC and Prescription Drug Products. Benjamin F. Banahan m and David J. McCaffrey, University of Mississippi, University. (abstract #52) 54. The Influence of Patient, PhysiCian, and State Regulatory Factors on Outpatient Drug Utilization. Linda J. WastiIa, Brandeis University, Brookline, Mass. (abstract #53) 55. An Assessment of Consumer Purchasing Behavior of Private Label vs. Brand Name Over-the-Counter Products in Chain Pharmacies. D.S. Sullivan, S.W. Birdwell, and S.N. Kucukarslan, Ohio State University, Columbus. (abstract #54) 56. Are Pharmacy Computer Databases Accurate for Tracking Medication Compliance? Donald o. Fedder, Sheila Curry, Sylvie Poirier, and Kenneth Coulter, University of Maryland, Baltimore. (abstract #55) 57. A Pilot Study of Barriers to Pharmacist-Patient Communication Reported by Pharmacists. Jon C. Schommer and Joseph B. Wiederholt, Sonderegger Research Center, University of Wisconsin-Madison. (abstract #56) 58. Female Pharmacists ' Practice Patte rns and Compensation. Richard P. D'Elia, Holly L. Mason, and Crystal S. Miller, Purdue University, West Lafayette, Ind. ; and Stephen W. Schondelmeyer, University of Minnesota, Minneapolis. (abstract #57)
59. Utilizatio n of Importance-Performance Analysis: Assessing Key Attributes of Asthma Medication. J.G. Boyer, A. Jones-Grizzle, and L.M. Jolicoeur, Glaxo Inc., Research Triangle Park, N.C. (abstract #58)
44. Measuring Consumer Involvement in Nonprescription Medicine Purchase Decisions. Prasanna Gore and Suresh Madhavan, West Virginia University, Morgantown. (abstract #43)
60. Appropriateness of Hz-Receptor Antagonist Prescribing for the Ambulatory Elderly. D.L McNally, S.M. Speedie, and S.]. Skarupa, University of Maryland, Baltimore. (abstract #59)
45. Credibility of the Sources of Information for Nonprescription Medicines: A Consumer Perception Study. Prasanna Gore and Suresh Madhavan, West Virginia UniverSity , Morgantown. (abstract #44)
61. Qualitative Exploration of Medication-Taking Behaviors in the Elderly. Lisa M. Stockwell. Richard M. Schulz, and C. Eugene Reeder, UniverSity of South Carolina, Columbia. (abstract #60)
46. Generic Utilization_Rates Across Therapeutic Categories with Changes in Insurance Program Design. C.R. Phillips, E.W. Jacobs, K.c. Farmer, and P.L. Lurvey, University of Oklahoma, Oklahoma City. (abstract #45)
62. Job and Career Satisfaction: Rural versus Urban Pharmacists. Marion K. Slack and Michelle Kikuchi, University of Arizona, Tucson. (abstract #61)
47. An Economic AnalYSis of the Pharmacist Labor Factor Market. David A. Mott and David H. Kreling, University of WisconsinMadison. (abstract #46)
AMERICAN PHARMACY
February 1992/162 Vol. NS32, No.2
11:15 Pharmacist Intervention in Smoking Cessation: A Review of the Literature. Kent H. Summers, University of Mississippi, University. (abstract #69) 11:40 Recruitment of State Pharmacy Association Members by Pharmacy Students. Robert P. Marshall, California Pharmacists Association, Los Angeles, and Julie Tennenhouse, Student Membership Recruiter, University of California , San Francisco . (abstract #72)
110 American Society for Pharmacy Law Contributed Papers I Saturday) March 14) 10:00 am-1:00pm 0.30 CEU
Podium Sessions The podium sessions are listed here, including the session number, category, day, date, paper titles, and times. Contributed paper podium sessions are 20- to 30-minute discussions, including a 5-minute question and answer period. Boldface indicates the principal author. Don't miss this "user friendly" way to participate in a valuable continuing education activity. Continuing education credit is offered for participation in podium sessions.
108 APhA/Academy of Pharmacy Practice and Management Contributed Papers Podium Session I Saturday) March 14) 10:00am-noon 0.20 CEU 10:00 Risk Perceptions of Self-Medication Practices. Yomma Tezino, Nawarut Charupatanapong, and Mary-Ann Galley, Texas Southern University, Houston. (abstract #63) 10:25 An Evaluation of Ni~e Risk Reduction Strategies for SelfTreatment. Nawarut Charupatanapong, Rashmi Gupta, and Mary Thompson, Texas Southern University, Houston. (abstract #64)
10:00 Drug Use Review in the Context of Recent Federal Legislation. Francis B. Palumbo, University of Maryland, Baltimore. (abstract #108) 10:20 Food and Drug Administration Approved Drugs for Unapproved Uses. Constant G. Marquer , Jr., and Brenda Thomas, Xavier University, New Orleans, La. (abstract #100) 10:40 Prozac: Side-Effects Causing a Nationwide Depression. J o se p h william Moch, Grand Rapids, Mich. (abstract #104) 11:00 Evaluating the Professional Competence of Pharmacists. Richard R. Abood, University of the Pacific, Stockton, Calif. (abstract #106) 11:20 The Pharmacist's Role in the Provision of Risk Management and Risk Assessment Information for Prescription Drugs: Preliminary Findings. Joseph B. Wie d erholt and Jon C. Schommer, University of Wisconsin-Madison, and David B. Brushwood, University of Florida, Gainesville. (abstract #102) 11:40 Interference with the Physician-Patient Relationship: A Potential New Avenue of Liability for the Pharmacist. Christopher P. Orlando, St. Clare's Hospital and Health Center, New York, N.Y. (abstract #99) 12:00 The Legal Ramifications of Special Dispensing Situation. Frederick H. Fern, Lester Schwab Katz & Dwyer, New York, N.Y. (abstract #96) 12:20 Pharmacist, Abortion, and Conscience. David B. Brushw ood, University of Florida, Gainesville. (abstract #97)
10:50 OTC Medication Recommendation by Retail Pharmacy Support Personnel: Prevalence and Governance by Store Policy. David J. McCaffrey ill, Benjamin F. Banahan III, and Mickey C. Smith, University of Mississippi, University. (abstract #67)
AMERICAN PHARMACY
February 1992/158 Vol. NS32, No.2
119 APhA/Academy of Pharmacy Practice and Management Contributed Papers Podium Session II
2:20 Physician Response to a Medicaid DUR Program. Earlene E. Lipowski, University of Florida , Gainesville, and Marion Becker, University of Wisconsin-Madison. (abstract #14)
Saturday, March 14, 2:00 pm-4:oo pm 0.20 CEU
2:40 Pharmacists' Reactions to a Medicaid DUR Program. Carolyn M. Brown and Earlene E. Lipowski, University of Florida, Gainesville. (abstract #15)
2:00 The Hispanic Patient: Challenges and Opportunities for Pharmacists. H.A. Monsanto, M. Rodriguez de Bittner, University of Maryland, Baltimore. (abstract #81) 2:25 Appropriateness of H2-Receptor Antagonist Prescribing for the Ambulatory Elderly. D.L. McNally, S.M. Speedie, and S.] . Skarupa, University of Maryland, Baltimore. (abstract #76) 2:50 Needs Assessment for a Third Class of Drugs: Results in Selected Consumer Samples. Marion K. Slack and Nancy A. Alvarez, University of Arizona, Tucson. (abstract #75) 3:15 The Role of Pharmacists in OTC Drug Product Selection Decisions: Review of the Literature. Kent H. Sununers and Foo Nin Ho, University of MissisSippi, University. (abstract #73)
3:40 Hepatitis B Immunization Program for Pharmacy Students. Hanaa Salm, Patrick Catania, Arthur Harralson, and Donald Sorby. University of the Pacific, Stockton, Calif. (abstract #82)
120 Economic, Social and Administrative Sciences Contributed Papers Podium Session I
3:00 Effect of Health Education on Health Service Utilization Among Hypertensive Patients Enrolled in Health Maintenance Organizations. D.A. ScIar and T.L. Skaer, Washington State UniverSity, Pullman; and A. Chin, M.P. Okamoto, R.K. Nakahiro, and M.A. Gill, University of Southern California, Los Angeles. (abstract #16) 3:20 Examination of Days Supply in Computerized Prescription Claims. Karen B. Farris, Barbara Kaplan, and Duane M. Kirking, University of Michigan, Ann Arbor. (abstract #17) 3:40 AsseSSing Compliance to Antihypertensive Medications Using Computer-Based Pharmacy Records. Dale B. Christensen, B. Williams, H. Goldberg, R. Engelberg, D. Martin, and ]. LoGerfo, University of Washington, Seattle. (abstract #18)
309 Nuclear Pharmacy Contributed Papers/Update Monday, March 16, 1:00-5:00 pm 0.40 CEU
Saturday, March 14, 2:00 pm-4:oo pm 0.20 CEU
Effectance vs. Effective Dose EqUivalent for Estimating Radiation Risk from Radiopharmaceuticals. James A. Ponto, University of Iowa, Iowa City. (abstract #88)
2:00 Pharmacist Self Concept, Predisposition to Communicate, Desire to Counsel, and Job Satisfaction. H.M. AndersonHarper, B.A. Berger, and O.R. Noel, Auburn University, Ala. (abstract #7)
Magnetic Resonance Spectroscopy and Nuclear Medicine. Kenneth T. Cheng, Timothy Nagel, and Kenneth M. Spicer, Medical University of South Carolina, Charleston. (abstract #90)
2:20 Relationships Between Patient Counseling Events, Prescription Payment Methods, and Practice Settings in Community Pharmacy. Dennis W. Raisch, University of New Mexico, Albuquerque. (abstract #8)
Preparation, Quality Control, and Clinical Investigation Using [llllIn-Labeled 1A3, A Monoclonal Anticolorectal Carcinoma Antibody for Patients. S.W. Schwarz, P.A. Rocque, c.]. Anderson, M.). Welch, ].M. Connett, and G.W. Philpott, Washington University Medical School, St. Louis, Mo. (abstract #93)
2:40 Pharmacists' Views of Patient Counseling: Preliminary Findings from a Statewide Study. Jon c. Schommer and Joseph B. Wiederholt; Sonderegger Research Center, University of Wisconsin-Madison. (abstract #9) 3:00 Determinant Attributes and Market Segments for Multiple Source Pharmaceuticals. Ebere F. Igboko and Joseph Thomas III, Purdue University, West Lafayette, Ind. (abstract #10) 3:20 An Investigation of the Importance of Certain Factors for HMO Drug Formulary Selection Decisions. Elizabeth C. Hanson, University of North Carolina, Chapel Hill; Marvin D. Shepherd , University of Texas , Austin ; and Andreas M. Pleil , Pharmaco. (abstract #11) 3:40 Relationship Between the Number of Firms and Generic Price Competition. ThanigaveIan Jambulingam and David H. Kreling, University of Wisconsin-Madison: (abstract #12)
201 Economic, Social and Administrative Sciences Contributed Papers Podium Session II Sunday, March 15, 2:00 pm-4:oo pm 0.20 CEU 2:00 Effect of Medication Utilization Review on Medicaid Health Care Expenditures: Four-Year Experience Among Patients with Non-Insulin-Dependent Diabetes Mellitus. D.A. ScIar and T.L. Skaer, Washington State University, Pullman. (abstract #13) Vol. NS32, No.2 February 19921159
Use of Bar Coding in the Nuclear Pharmacy. Robert F. Gutkowski, William C. Porter, and Jack c. Hill, William Beaumont Hospital, Royal Oak, Mich. (abstract #94) Source, Magnitude and Possible Solutions to Potential Radioactive Releases During Production of [18F1Fluorodeoxyglucose (FDG). G. Leonard Watkins, Richard D. Hichwa, John C. Richmond, and Laura L Boles Ponto, University of Iowa, Iowa City. (abstract #95)
400 Economic, Social and Administrative Sciences Contributed Papers Podium Session III Tuesday, March 17, 8:00am-10:ooam 0.20 CEU 8:00 Drug Use Behavior Beyond the Medicaid Prescription Cap. Richard M. Schulz, Sandy Chubon, Marcy Coster-Schulz, and Earle W. Lingle, University of South Carolina, Columbia. (abstract #19) 8:20 Use of Home Remedies and OTC Products Among Rural Residents at High Risk for Development of Coronary Heart Disease. Benjantin F. Banahan m and Dennis A. Frate, University of MissiSSippi, University. (abstract #20) 8:40 Clients' Experience of Side Effects and Discontinuation of Oral Contraceptives. Betty Chewning and Dale Wilson, Son-
AMERICAN PHARMACY
deregger Research Center, University of Wisconsin-Madison. (abstract #21) The Effect of Patient's Age and Payment Method on Satisfaction w ith Pharmacy Services. Lon N. Larson, Drake University, Des Moines, Iowa, and Linda D . MacKeigan, Ohio State University, Columbus. (abstract #22)
Medical Utilization of Elderly Hypertensives. L. Douglas Ried, University of Florida, and Richard E. Johnson, Center for Health Research, Gainesville, Fla. (abstract #26)
3:20
9:00
Quality of Life for Parents of Children with Asthma . Joseph T. Dye, Richard M. Schulz, Lynn M. Jolicoeur, and Thomas P. Cafferty, University of South Carolina, Columbia. (abstract #23)
9:20
Estimating Sample Sizes from an Elderly Population. Chris M. Kozma, Earle W. Lingle, and ].S. Roberts, University of South Carolina, Columbia. (abstract #24)
The Use of Antibiotics in Saskatchewan. Jeffrey S. McCombs and Michael B. Nichol, University of Southern California , Los Angeles. (abstract #27)
3:40
Zidovudine Use Among Symptomatic HIV Cases in the New York State Medicaid Program, 1987-1989. Leon E. CosIer, Lynne Oetjen-Gerdes, and Thomas R Fanning, New York State Dept. of Social Services, New York; Leona E. Markson and Barbara ]. Turner, Jefferson Medical College, New York. (abstract #28)
4:00
9:40
409 American Society for Pharmacy Lavv Contributed Papers II
Differences in Prescribing Rates Among Rural and Urban Physicians: An Analysis of the National Ambulatory Medical Care Survey. David W. Miller and Stuart M. Speedie, University of Maryland, Baltimore. (abstract #29)
4:20
Physicians' Product Class Choice in Treating Mild Hypertension: A National Survey of a Sample of Physicians. J. Martin Jernigan, Mickey C. Smith, Benjamin F. Banahan III, John P. Juergens, and Thomas R Sharpe, University of Mississippi, University. (abstract #30)
4:40
Tuesday, March 17, 8:30 am-ll:30 am 0.30 CEU Legal Status of the Pharmacist as an Employee. Robert A. Hollenbeck, Hospital of St. Raphael, New Haven, CT. (abstract #109)
8:30
The Wisconsin Pharmacy Self-Inspection Project: An Application of the Theory of Continuous Improvement. Jon C. Schommer, Joseph B. Wiederholt, and T.D. McGregor, University of Wisconsin-Madison. (abstract #101)
8:50
Regulation of Pharmacist Time and Workplace Conditions-Necessary or Overly Burdensome? Michelle Dains, Texas State Board of Pharmacy, Austin. (abstract #103)
9:10
Adapting the Public Utility Model to Health Care Systems: Focus-Pharmaceutical Care. Richard A. Angorn and Maria A. Miralles, University of Florida, Gainesville. (abstract #98)
9:30
A Survey of Pharmacist Patient Counseling Laws by State and Their Impact on Pharmacy Practice. Deborah A. Carlino and Norman A. Campbell, University of Rhode Island, Kingston. (abstract #111)
9:50
10:10 The Public Policy and Economic Implications of DUR for Pharmacy. Jennifer L. Tebbe and F. Randy Vogenberg, Mas-
sachusetts College of Pharmacy and Allied Health Sciences, Boston. (abstract #107)
Poster Sessions Sunday, March 15, 11:00 am-3:00pm Monday, March 16, 11:00 am-3:00 pm Tuesday, March 17, 11:00 am-3:00 pm
This year there will be four poster sessions. The APhA Contributed Papers Poster Sessions will be held on Sunday, Monday, and Tuesday. Authors will be present on Sunday only. The Economic, Social and Administrative Sciences (ESAS) Contributed Papers Poster Session will be held only on Sunday with authors present. (No CE credit is offered.)
Academy of Pharmaceutical Research & ScienceIBasic Sciences Contributed Papers Poster Session 1.
Effect of pH on the Dissolution of Commercially Available Procainamide Controlled-Release Products. Ashesh]. Gandhi and J. Grady Strom, Jr., Mercer University, Atlanta, Ga . (abstract #1)
2.
Radiopharmaceutical Metabolism by Cultured Hepatocytes: Validation of Methodology Using [1-123Hofetamine. S.M. MoerIein, RA. Weisman, D. Beck, A.P . Li, and M.J. Welch, Washington University School of Medicine and Monsanto Corporation, St. Louis, Mo. (abstract #2)
3.
Preparation of Gallium-68 Labeled Human Lipoproteins for PET Assay of Tissue LDL Receptor Activity. S.M. Moerlein, C. Yahng, and MJ. Welch, Mallinckrodt Institute of Radiology, Washington University, St. Louis, Mo. (abstract #3)
412 Economic, Social and Administrative Sciences Contributed Papers Podium Session IV
4.
Encapsulation of High Molecular Weight DNA and Release from Calcium Alginate Hydrogels. Timothy J. Smith, Indiana University, Terre Haute. (abstract #4)
Tuesday, March 17, 3:00pm-5:00 pm 0.20 CEU
5.
Evaluation of Maltodextrins as Tablet Excipients: I Micromeritic and Compressional Characterization. Shelli Nath and Yashwant V. Pathak, South Dakota State University, Brookings. (abstract #5)
10:30 Consumer Protection Issues Surrounding the Mail Order Prescription Controversy. Norman A. Campbell, University of
Rhode Island, Kingston. (abstract #110) 10:50 A Call for the Use of Conflict of Laws Doctrine to Enforce
State Board Regulation of Mail-Order Pharmacy. Gregory J. Wood, Canton, Ohio. (abstract #112) 11:10 Litigation Between Pharmaceutical Manufacturers: 1980--Present. Martha M. Rwnore, Alan Pescheria, and Steven S. Strauss, Arnold & Marie Schwartz College of Pharmacy, New
York, N.Y. (abstract #105)
Health Care Costs and Antihypertensive Drug Therapy. J.S. McCombs, D.A. Sclar, M.B. Nichol, and C.M. Newman, University of Southern California, Los Angeles. (abstract #25)
3:00
AMERICAN PHARMACY
February 1992/160 Vol. NS32, No.2
6.
In Vitro Adsorption and Desorption Studies of Sulindac with Antacids . Fotios M. Plakogiannis, Tahmina Z. Mannan , Theodore Jochsberger, and Almas Babar, Long Island University, Brooklyn, N.Y. (abstract #6)
Academy of Pharmacy Practice and Management Contributed Papers Poster Session National Hospice Pharmacy Survey. Stephen G. Arter, Parkview Memorial Hospital, Fort Wayne, Ind., and Joni 1. Berry, Hospice of Wake County, Raleigh, N.C. (abstract #62)
7.
8.
Using the Delphi Technique to Determine Guidelines for Developing a Community Pharmacy Clinical Clerkship Model. J.H. McDermott, S.M. Caiola , and K.F. Kuhn, University of North Carolina, Chapel Hill. (abstract #65)
9.
Development of an Industrial Pharmacy Career Curriculum Option. Z. Tom Grapes and Richard A. Jackson, Mercer University, Atlanta, Ga. (abstract #66)
10. Development of an In-House Clinical Skills Development Program. Andrew J. Donnelly, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Ill. (abstract #68) 11. Streamlining an OB Anesthesia Work Area Through Stock Revision and Policy and Procedure Enhancement. Julie A. Golembiewski, University of Illinois Hospital, Chicago. (abstract #70)
12. Creation of the California Pharmacy Council. Robert P. Marshall, California Pharmacisl~ Association, Los Angeles, and Teresa A. Miller, California Society of Hospital Pharmacists. (abstract #71) 13. Job and Career Satisfaction: Rural versus Urban Pharmacists. Marion K. Slack and Michelle Kikuchi, University of Arizona, Tucson. (abstract #74)
Academy of Students of Pharmacy Contributed Papers Poster Session 22. Student Awareness of and Extent of Participation in State Pharmaceutical Association Activities. H.A. Monsanto and S.l. Lugo, University of Maryland, Baltimore; E. Vega, 1. IgleSias, and F. Morales, University of Puerto Rico, San Juan. (abstract #113)
Nuclear Pharmacy Contributed Papers Poster Session 23. Establishment and Economic Feasibility of Nuclear Pharmacy Services in a Rural Community Setting. David 1. Laven, Veterans Affairs Medical Center, Bay Pines, Fla., and Timothy M. Quinton, Radiopharmacy, Inc., Evansville, Ind. (abstract #89) 24. An Innovative Nuclear Pharmacy Service: A Comprehensive Management Plan for Clinical Investigations. K.T. Chen, B.M. Brown, M.S. Sheppard, and D.]. Haymond, Medical University of South Carolina, Charleston. (abstract #91) 25. A Study to Investigate Preparation Parameters of TC-99M Teboroxime . B.M. Brown, K.T. Cheng, M.S. Sheppard, and D.] . Haymond, Medical University of South Carolina, Charleston. (abstract #92)
APhA Merck Student Pharmacy Project Grants 26. Geriatric Patient Drug Education Program. The APhA-ASP Chapter at Purdue University, West Lafayette, Ind. (abstract #114)
14. Evaluation of Unclaimed Prescriptions in an Ambulatory Care Pharmacy. Marilyn H. Kirking and Duane M. Kirking, University of Michigan, Ann Arbor. (abstract #77)
27. The Impact of Pharmacy Education to High School Students on the Prevention of Acquired Immunodeficiency Syndrome (AIDS). The APhA-ASP Chapter at Rutgers University, Piscataway, N.]. (abstract #115)
15. An Analysis of the Financial Impact of Third Party Programs on Community Pharmacy. Cheryl Huey, Richard A. Jackson, and Margaret A. Piril, Mercer University, Atlanta, Ga. (abstract #78)
28. The Use of Poison Control Stickers to Prevent the High Incidence of Poison Related Injuries and Deaths. The APhA-ASP Chapter at the University of the Pacific, Stockton, Calif. (abstract #116)
16. Medication Management and Compliance in Assisted Living Facilities (ALF). L Maine, N. Barfield, M. Feemster, and B. Murray, Samford University, Birmingham, Ala. (abstract #79)
29. Establishment of a Pharmacy Student Council on Substance Abuse Education. The APhA-ASP Chapter at the University of Utah, Salt Lake City. (abstract #117)
17. Misconceptions and Use of Vitamin/Mineral Supplements in the Low Income Elderly. Mary Thompson, Nawarut Charupatanapong, and Mary-Ann Galley, Texas Southern University, Houston. (abstract #80)
30. "Ask Your Pharmacist" Informational Radio Announcements. The APhA-ASP Chapter at the University of Oklahoma, Oklahoma City. (abstract #118)
18. A Comparison of On-Line Prospective DUR in a Medicaid Versus a Non-Medicaid Population. Pat Mundy, Pharmacist Consultant for The Computer Company of Virginia, Glen Allen. (abstract #83) 19. Educating the Patient's Families on Their Level. Judy Ann Knapp and Victoria Hyde, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. (abstract #84) 20. Pharmacoeconomic Impact of GERD-A Feasibility Study in a Community Pharmacy. LJ. Kirchdoerfer, Glaxo Inc., Research Triangle Park, N.C. , and R.]. Osterhaus and M.C. Osterhaus, Osterhaus Pharmacy, Inc. , Maquoketa, Iowa. (abstract #85) 21. The FDA Drug Quality Reporting System and Drug Shortage Program. Anita M. Dopkosky and George R. Bolger, FDA, Rockville, Md. (abstract #120)
Vol. NS32, No.2 February 1992/161
31. EmbraCing me Future: Coping with the Stresses of a Changing Profession. A MultidiSCiplinary Conference. The APhA-ASP Chapter at Drake University, Des Moines, Iowa. (abstract #119)
Economic, Social, and Administrative Sciences Contributed Papers Poster Session 32. The Impact of the Rhode Island Duplicate Prescription Law on Prescribing Practices for Schedule II Drugs-Part 1. Self-Stated Effect of the Law on Drug Regimen Decision-Making Process. Bridgit A. Anness, Cynthia]. Willey, Albert H. Taubman, Norman A. Campbell, and Charles Hacadorian, University of Rhode Island, Kingston. (abstract #31)
AMERICAN PHARMACY
33. The Impact of the Rhode Island Duplicate Prescription Law on Prescribing Practices for Schedule II Drugs---Part II. Self-Stated Effect of the Law on Therapeutic Preference to Choose an Alternative Drug to a Clearly Indicated Schedule II Drug. Bridgit A. Anness, Cynthia J. Willey, Albert H. Taubman, Norman A. Campbell, and Charles Hachadorian, University of Rhode Island, Kingston. (abstract #32)
48. Prescription Payer Mix Analysis of a Nationwide Secondary Database. Paul G. Rosowski and David H. Kreling, University of Wisconsin-Madison. (abstract #47)
34. Do Mandatory Consultation and Patient Profile Laws Represent New Professional Standards or Simply Wishful Thinking? Lucy Michael and Michael B. Nichol, University of Southern California, Los Angeles. (abstract #33)
50. Pharmacists' Expectations vs. Satisfactions with Brand Name Manufacturers. Puneet Mahajan, Harvey Rappaport, Kai Wong, and Priti Jhingran, Northeast Louisiana University, Monroe. (abstract #49)
35. Needs Assessment for a Third Class of Drugs: Results in Selected Consumer Samples. Marion K. Slack and Nancy A. Alvarez, University of Arizona, Tucson. (abstract #34)
51. Product Attributes Considered in the Selection of an Rx-toOTC Switch Candidate: The Opinion of the Pharmaceutical Marketing Executives. Priti Jhingran, Harvey Rappaport, Joseph Feldhaus, Aubrey Magoun, and William Weirick, Northeast Louisiana University, Monroe. (abstract #50)
36. Impact of a Discounted AWP on Drug Product Selection for Medicaid Prescriptions. Dean Arneson, Ferris State UniverSity, Big Rapids, Mich.; Elgene Jacobs, University of Oklahoma, Oklahoma City; and James R. Schmidt, University of Nebraska , Omaha. (abstract #35)
37. Physician Prescribing Decisions: The Effects of Situational Involvement and Task Complexity on Information Acquisition and Decision Making. Vigit Chinburapa, West Virginia University, Morgantown; Lon N. Larson, Drake UniverSity, Des Moines; J. Lyle Bootman, JoLaine Draugalis, Merrie Brucks, and Christopher P. Puto, University of Arizona , Tucson. (abstract #36) 38. The Importance of Side Effects in Differentiating Prescription Drug Products. Vigit Chinburapa, West Virginia University, Morgantown, and Lon N. Larson, Drake UniverSity, Des Moines, Iowa. (abstract #37) 39. Practical Evaluation of the Psychometric Properties of a Disease Specific Quality of Life Instrument in Clinical Practice. J.T. Lee and J.D. Hirsch, Glaxo Inc. Research Institute, Research Triangle Park, N.C. (abstract #38) 40. An AnalysiS of the Cost of Dispensing Third Party and Private Pay Prescriptions in Rhode Island. Kenneth W. Schafenneyer and Renato Cataldo, Jr., St. Louis College of Pharmacy, St. Louis, Mo. (abstract #39) 41. Disease and Therapy Characteristics of Home Infusion Therapy Patients. Chris M. Kozma, Bryan J. Lawrence, and C. Eugene Reeder, University of South Carolina, Columbia. (abstract #40)
42. Characterization of the Home Infusion Market in North Carolina and Florida. Terri Young, Chris M. Kozma, C. Eugene Reeder, and Earle W. Lingle, University of South Carolina, Columbia. (abstract #41) 43. Adequacy of the FDA's Prescription to Over-the-Counter Switch Evaluation Criteria: An Empirical Investigation. Suresh Madhavan, West Virginia University, Morgantown. (abstract #42)
49. Consumer Selection of Generic and Brand Name Prescription Medications After a Brand Name Petition Process. K.c. Fanner, E.W. Jacobs, and c.R. Phillips, University of Oklahoma, Oklahoma City. (abstract #48)
52. Product Attribute Importance in Evaluating a New Antihypertensive Product Among a Sample of Physicians. J. Martin Jernigan, Mickey C. Smith, Benjamin F. Banahan III , John P. Juergens, and Thomas R. Sharpe, University of Mississippi, UniverSity. (abstract #51)
53. Rural High School Students' Attitudes Toward and Use of OTC and Prescription Drug Products. Benjamin F. Banahan m and David J. McCaffrey, University of Mississippi, University. (abstract #52) 54. The Influence of Patient, PhysiCian, and State Regulatory Factors on Outpatient Drug Utilization. Linda J. WastiIa, Brandeis University, Brookline, Mass. (abstract #53) 55. An Assessment of Consumer Purchasing Behavior of Private Label vs. Brand Name Over-the-Counter Products in Chain Pharmacies. D.S. Sullivan, S.W. Birdwell, and S.N. Kucukarslan, Ohio State University, Columbus. (abstract #54) 56. Are Pharmacy Computer Databases Accurate for Tracking Medication Compliance? Donald o. Fedder, Sheila Curry, Sylvie Poirier, and Kenneth Coulter, University of Maryland, Baltimore. (abstract #55) 57. A Pilot Study of Barriers to Pharmacist-Patient Communication Reported by Pharmacists. Jon C. Schommer and Joseph B. Wiederholt, Sonderegger Research Center, University of Wisconsin-Madison. (abstract #56) 58. Female Pharmacists ' Practice Patte rns and Compensation. Richard P. D'Elia, Holly L. Mason, and Crystal S. Miller, Purdue University, West Lafayette, Ind. ; and Stephen W. Schondelmeyer, University of Minnesota, Minneapolis. (abstract #57)
59. Utilizatio n of Importance-Performance Analysis: Assessing Key Attributes of Asthma Medication. J.G. Boyer, A. Jones-Grizzle, and L.M. Jolicoeur, Glaxo Inc., Research Triangle Park, N.C. (abstract #58)
44. Measuring Consumer Involvement in Nonprescription Medicine Purchase Decisions. Prasanna Gore and Suresh Madhavan, West Virginia University, Morgantown. (abstract #43)
60. Appropriateness of Hz-Receptor Antagonist Prescribing for the Ambulatory Elderly. D.L McNally, S.M. Speedie, and S.]. Skarupa, University of Maryland, Baltimore. (abstract #59)
45. Credibility of the Sources of Information for Nonprescription Medicines: A Consumer Perception Study. Prasanna Gore and Suresh Madhavan, West Virginia UniverSity , Morgantown. (abstract #44)
61. Qualitative Exploration of Medication-Taking Behaviors in the Elderly. Lisa M. Stockwell. Richard M. Schulz, and C. Eugene Reeder, UniverSity of South Carolina, Columbia. (abstract #60)
46. Generic Utilization_Rates Across Therapeutic Categories with Changes in Insurance Program Design. C.R. Phillips, E.W. Jacobs, K.c. Farmer, and P.L. Lurvey, University of Oklahoma, Oklahoma City. (abstract #45)
62. Job and Career Satisfaction: Rural versus Urban Pharmacists. Marion K. Slack and Michelle Kikuchi, University of Arizona, Tucson. (abstract #61)
47. An Economic AnalYSis of the Pharmacist Labor Factor Market. David A. Mott and David H. Kreling, University of WisconsinMadison. (abstract #46)
AMERICAN PHARMACY
February 1992/162 Vol. NS32, No.2